Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. Dec. 19, 2018. William Maisel.

Executive Summary

The acting compliance office chief for US FDA's device center, William Maisel, was giddy about the growth and popularity of the Medical Device Single Audit Program during a recent Food & Drug Law Institute conference in Washington, DC. See what he said about MDSAP here.

“We believe MDSAP will and should grow. The key elements we’re thinking about are how to best share the information between governments, and how to use audit reports from participating authorities.” –William Maisel, acting compliance office director, US FDA

Click here for a free trial of Medtech Insight

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts